Atrial Fibrillation, Deep Vein Thrombosis, Pulmonary Embolism
Conditions
Brief summary
Pharmacists are in the best position to counsel and educate patients on anticoagulant agents such as NOACs. This should enable patients to play a more active role in their treatment and ultimately enhance adherence behaviour. However, educational elements should be targeted to knowledge. Thus, the investigators will develop and validate a questionnaire that can assess knowledge about NOACs
Interventions
BEHAVIORALEducation
Patients will receive several questionnaires to fill in. Knowledge about NOACs will be assessed with a newly developped questionnaire and an educational program will be dispensed while analysing the answers (reactive educational program).
Sponsors
University of Basel
University Hospital, Basel, Switzerland
Study design
Observational model
OTHER
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Intake of a NOACs (Rivaroxaban, Edoxaban, Dabigatran, Apixaban) * ≥18 years * Able to give written Informed consent in German
Exclusion criteria
* NOACs for orthopaedic indication * Dementia in medical history
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Test retest validity of the new questionnaire | 7 days | Number of correct/incorrect answers measured at visit 1 and 2 (0 respectively 7 days after visit 1) |
| Validation of the new questionnaire assessed by questionnaire | measured once at visit 1 (baseline) | Patients will rate on a 4-point likert scale feasibility, acceptability and comprehension of the new questionnaire immediately after the questionnaire had been filled in the first time. |
| Sensitivity of the new questionnaire | 7 days after visit 1, before and after the educational program | Number of correct/incorrect answers measured at visit 2 before and after the educational program has been dispensed (7 days after visit 1) |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Patient's satisfaction assessed by questionnaire | 14 days | change in satisfaction between visits 1 (baseline) and visit 3 |
| Patient's health literacy assessed by questionnaire | assessed once at visit 1 (baseline assessment) | — |
| Patient's adherence assessed by questionnaire | 14 days | change in adherence between visits 1 (baseline) and visit 3 |
Other
| Measure | Time frame |
|---|---|
| Number of patients having an anticoagulation identification card | assessed once at visit 1 (baseline assessment) |
Countries
Switzerland
Outcome results
None listed